OGN icon

Organon & Co

721 hedge funds and large institutions have $3.01B invested in Organon & Co in 2025 Q1 according to their latest regulatory filings, with 82 funds opening new positions, 226 increasing their positions, 228 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more call options, than puts

Call options by funds: $31.7M | Put options by funds: $25.4M

1% less repeat investments, than reductions

Existing positions increased: 226 | Existing positions reduced: 228

10% less capital inflows, than outflows

Capital inflows: $357M | Capital outflows: $395M

1.31% less ownership

Funds ownership: 79.87% → 78.56% (-1.3%)

3% less funds holding

Funds holding: 741 → 721 (-20)

12% less first-time investments, than exits

New positions opened: 82 | Existing positions closed: 93

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
721
Holders Change
-20
Holders Change %
-2.7%
% of All Funds
9.64%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
82
Increased
226
Reduced
228
Closed
93
Calls
$31.7M
Puts
$25.4M
Net Calls
+$6.28M
Net Calls Change
+$2.45M

OGN Hedge Fund Activity: Q1 2025 in Review

721 of the 7,478 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q1 2025, worth a combined $3.01B — down 2% from $3.07B a quarter earlier.

Sellers outnumbered buyers: 93 funds closed out of OGN and 82 opened new positions — a net loss of 11 holders — while 228 trimmed existing stakes and 226 added.

The largest buyer was Citadel Advisors, adding an estimated $61.6M. The largest seller was Pacer Advisors, exiting entirely with an estimated $166M sold.

  • 721 institutional investors held Organon & Co (OGN) as of Q1 2025, down from 741 in Q4 2024.
  • Funds reported $3.01B of Organon & Co stock for Q1 2025, down 2% quarter-over-quarter.
  • 82 funds opened new Organon & Co positions in Q1 2025 and 93 closed out, a net change of -11 holders.
  • The largest Organon & Co buyer in Q1 2025 was Citadel Advisors, an estimated $61.6M added.
  • The largest Organon & Co seller in Q1 2025 was Pacer Advisors, an estimated $166M sold.

Based on aggregated 13F filings for Q1 2025.